Molecular Genetic Mechanisms in Age-Related Macular Degeneration

Abstract

Age-related macular degeneration (AMD) is among the leading causes of irreversible blindness worldwide. In addition to environmental risk factors, such as tobacco use and diet, genetic background has long been established as a major risk factor for the development of AMD. However, our ability to predict disease risk and personalize treatment remains limited by our nascent understanding of the molecular mechanisms underlying AMD pathogenesis. Research into the molecular genetics of AMD over the past two decades has uncovered 52 independent gene variants and 34 independent loci that are implicated in the development of AMD, accounting for over half of the genetic risk. This research has helped delineate at least five major pathways that may be disrupted in the pathogenesis of AMD: the complement system, extracellular matrix remodeling, lipid metabolism, angiogenesis, and oxidative stress response. This review surveys our current understanding of each of these disease mechanisms, in turn, along with their associated pathogenic gene variants. Continued research into the molecular genetics of AMD holds great promise for the development of precision-targeted, personalized therapies that bring us closer to a cure for this debilitating disease.

Multidisciplinary Approaches in the Treatment of Retinal Degenerative Diseases: A Review

“…RDDs include age-related macular degeneration (AMD) and inherited retinal degeneration (IRD). Both genetic and environmental risk factors are involved in AMD, [3,4] whereas IRD is mainly monogenetic, with a common Mendelian inheritance. [5] AMD slowly degenerates the central retina and is the most prevalent cause of blindness in the older population.…”